Stryve Foods, Inc. Warrant
SNAXW
SNAXW was delisted on the 4th of February, 2025.
12 hedge funds and large institutions have $134K invested in Stryve Foods, Inc. Warrant in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
9% more funds holding
Funds holding: 11 → 12 (+1)
26% less capital invested
Capital invested by funds: $182K → $134K (-$48K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$3.12K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$1.36K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$744 |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$85 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$1.45K |
| 2 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$477 |
SNAXW Hedge Fund Activity: Q3 2022 in Review
12 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Stryve Foods, Inc. Warrant (SNAXW) for Q3 2022, worth a combined $134K — down 26% from $182K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new SNAXW positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Cowen and Company, adding an estimated $3.12K. The largest seller was HRT Financial, cutting an estimated $1.45K.
- 12 institutional investors held Stryve Foods, Inc. Warrant (SNAXW) as of Q3 2022, up from 11 in Q2 2022.
- Funds reported $134K of Stryve Foods, Inc. Warrant stock for Q3 2022, down 26% quarter-over-quarter.
- 1 fund opened new Stryve Foods, Inc. Warrant positions in Q3 2022 and 0 closed out, a net change of +1 holder.
- The largest Stryve Foods, Inc. Warrant buyer in Q3 2022 was Cowen and Company, an estimated $3.12K added.
- The largest Stryve Foods, Inc. Warrant seller in Q3 2022 was HRT Financial, an estimated $1.45K sold.
Based on aggregated 13F filings for Q3 2022.